[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-370062-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-370062-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","elimusertib-a-novel-atr-inhibitor-induces-anti-tumor-effects-through-replication-catastrophe-in-breast-cancers","Elimusertib, a Novel ATR Inhibitor, Induces Anti-tumor Effects through Replication Catastrophe in Breast Cancers","","Elimusertib, an ATR inhibitor, was investigated for antitumor activity and its mechanism in breast cancer. Purpose-driven rationale links sustained proliferation to replication stress and DNA damage, with ATR as a key regulator of the DNA damage response. In vitro and in vivo studies evaluated anti-tumor effects, cell cycle changes, DNA damage, and apoptosis. Results showed S-phase delay, caspase-7–dependent apoptosis, ssDNA accumulation, and replication catastrophe, with heightened sensitivity in high-replication-stress settings.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/elimusertib-a-novel-atr-inhibitor-induces-anti-tumor-effects-through-replication-catastrophe-in-breast-cancers/370062/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/elimusertib-a-novel-atr-inhibitor-induces-anti-tumor-effects-through-replication-catastrophe-in-breast-cancers/370062.png","ImageObject",300,407,{"name":42,"@type":43},"LangkahRina","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-13","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",7,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What biological process does elimusertib target in breast cancer cells?","Question",{"text":63,"@type":64},"Elimusertib inhibits ATR, a central kinase that coordinates cellular responses to replication stress and DNA damage. This disruption increases replication stress and DNA damage, contributing to cell death.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were antitumor effects and mechanism assessed in the study?",{"text":68,"@type":64},"Antitumor effects were evaluated using MTT and colony formation assays in vitro, and xenograft plus patient-derived xenograft models in vivo. Cell cycle changes were measured by flow cytometry and BrdU assay, while DNA damage was assessed using alkaline and neutral comet assays.",{"name":70,"@type":61,"acceptedAnswer":71},"What role does replication catastrophe play in the reported findings?",{"text":72,"@type":64},"Replication fork stalling and aberrant ssDNA accumulation during S-phase culminate in replication catastrophe. This sequence supports the mechanism underlying elimusertib-induced apoptosis and antitumor effects, especially in cells with high replication rates.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},370062,1790210454,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":108,"preview_page_count":33,"preview_urls":145},962090893776,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","pISSN 1598-2998, eISSN 2005-9256  \n\n| [https://doi.org/10.4143/crt.2024.1105](https://doi.org/10.4143/crt.2024.1105) Cancer Res Treat. 2026;58(1):159-174\u003Cbr>\u003Cbr>Original Article\u003Cbr>Elimusertib, aNovelATR Inhibitor, Induces Anti-tumor Effects through Replication Catastrophe in Breast Cancers\u003Cbr>Mudong Kim1 , Ahrum Min1,2 , Sohyeon Kim1 , Seongyeong Kim1 , Yu-jin Kim1 , Sujin Ham1 , Miso Lee1 , Eunice Yoojin Lee3 , Jinyong Kim1,4 , Dae-Won Lee1,4,5 , Kyung-Hun Lee1,4 , Seock-Ah Im1,2,4,5\u003Cbr>1Cancer Research Institute, Seoul National University, Seoul, 2Biomedical Research Institute, Seoul National University Hospital, Seoul, Korea, 3Department of Internal Medicine, University of California San Francisco, San Francisco, CA, USA, 4Department of Internal Medicine, Seoul National University Hospital, Seoul, 5Department of Internal Medicine and Translational Medicine, Seoul National University College of Medicine, Seoul, Korea |  |\n| --- | --- |\n| Purpose Sustained cell proliferation and cell cycle acceleration in cancer cells inherently increase DNA damage, which interferes with homeostatic replication and transcription. Ataxia telangiectasia and Rad3-related (ATR) is crucial for initiation of the DNA damage response, and ATR inhibitors, such as elimusertib, induce increased replication stress and DNA damage. We investigated the antitumor effects of elimusertib and its mechanism of action in relation to replication stress.\u003Cbr>Materials and Methods Anti-tumor effects were evaluated by MTT assay and colony formation assay in breast cancer cell lines in vitro, in breast cancer cell xenografts in vivo, and in patient-derived xenograft models. Cell cycle was assessed by flow cytometry and BrdU assay was used to measure replicating cells and S-phase progression. Alkaline and neutral comet assay was used to measure single and double-stranded DNA damages, respectively.\u003Cbr>Results Elimusertib delayed S-phase progression in MDA-MB-453 and MDA-MB-231 cells and induced caspase-7–dependent apoptosis. Furthermore, the increase in sub-G1 population in the fluorescence-activated cell sorting analysis and Annexin V assay also confirmed apoptotic cell death. In the BrdU assay, single-stranded DNA (ssDNA) increased in sensitive cells and aberrant ssDNA induced DNA damage in S-phase and eventually caused replication catastrophe. Finally, these anti-tumor effects were proven in in vivo xenograft and patient-derived xenograft models.\u003Cbr>Conclusion Elimusertib had anti-tumor effects and induced replication catastrophe in breast cancer cells with a high replication rate. Moreover, cells under high DNA replication stress were sensitive to elimusertib. Further studies and treatment strategies withelimusertib are warranted for cancers with a high replication rate.\u003Cbr>Key words ATR inhibitor, DNA damage, Cell cycle progression, Replication stress, Replication catastrophe |  |\n| Introduction | tein kinase. Both kinases respond to DNA double-stranded breaks (DSBs). However, ATR plays a critical role in the cel- |\n| Sustained and unchecked cellular proliferation is a major | lular response to replication stress and DNA damage [2] . |\n| hallmark of cancer [1] . Cells employ evolutionarily con- | ATR acts as a replication stress checkpoint as a surveillant |\n| served mechanisms to ensure the faithful replication and | by monitoring and responding to problems that arise during |\n| transmission of genetic material to their progeny, including | DNA replication. When DNA replication is stalled or slowed |\n| the highly complex task of coordinating DNA replication | due to stress or damage, ATR is activated and coordinates a |\n| fork progression. Slowing or stalling of replication fork pro- | series of cellular responses to stabilize the replication fork, |\n| gression—a phenomenon referred to as replication stress—is | promote DNA repair, and control cell cycle progression. This |\n| a primary cause of genomic instability, a second hallmark of | helps maintain genomic int","cbCaiqVldCsgj6Va","https://ap.wps.com/l/cbCaiqVldCsgj6Va","pdf",3798337,16,"English","# Purpose\n# Materials and Methods\n# Results\n# Conclusion\n# Introduction\n# Correspondence and Publication Information","[{\"question\":\"What biological process does elimusertib target in breast cancer cells?\",\"answer\":\"Elimusertib inhibits ATR, a central kinase that coordinates cellular responses to replication stress and DNA damage. This disruption increases replication stress and DNA damage, contributing to cell death.\"},{\"question\":\"How were antitumor effects and mechanism assessed in the study?\",\"answer\":\"Antitumor effects were evaluated using MTT and colony formation assays in vitro, and xenograft plus patient-derived xenograft models in vivo. Cell cycle changes were measured by flow cytometry and BrdU assay, while DNA damage was assessed using alkaline and neutral comet assays.\"},{\"question\":\"What role does replication catastrophe play in the reported findings?\",\"answer\":\"Replication fork stalling and aberrant ssDNA accumulation during S-phase culminate in replication catastrophe. This sequence supports the mechanism underlying elimusertib-induced apoptosis and antitumor effects, especially in cells with high replication rates.\"}]","Elimusertib, a Novel ATR Inhibitor, Induces Anti-tumor Effects through Replication Catastrophe in Breast Cancers | PDF",1790186540,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/022d655df40fe05e33446acd12a9cc1e.webp",983,1310,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c30852070c9c05b8c3ba206c671b3c03.webp",982,1309,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c552ef8767838dea60d1d1d0a14cc063.webp",981,1308,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ff766ff89459adaa28482a56cb1c4089.webp",980,1306]